Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

OBJECTIVES:

Assess the safety and long-term efficacy of monoclonal factor IX concentrate in patients with factor IX deficiency.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Center for Research Resources (NCRR)
• Collaborator: University of North Carolina

Criteria

PROTOCOL ENTRY CRITERIA:

Patients with factor IX deficiency.